Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Chao Zhao

Title(s)Associate Specialist, Neurology
SchoolSchool of Medicine
ORCID ORCID Icon0000-0001-7192-7856 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Georgia State University, Atlanta, GAMS2016Statistics

    Collapse Overview 
    Collapse Overview
    SAS9 Global Certified Clinical Trials Programmer, Certificate No.: CTP001080v9 - 2016
    SAS9 Global Certified Advance Programmer, Certificate No.: AP017233v9 – 2016
    SAS9 Global Certified Base Programmer, Certificate No.: BP056864v9 – 2016

    Standard statistical supports for EPIC, ORIGINS, and SUMMIT cohorts at UCSF Multiple Sclerosis Center. Analyses include:
    • Parametric/Nonparametric Statistics.
    • Descriptive (Numerical Summary/Data Visualization)/Inference Statistics (Frequentist/Bayesian).
    • Cross-sectional Analyses: Parametric/Nonparametric Tests.
    • Longitudinal Analyses (Time): Linear/Quadratic/Spline Mixed-effects Model, Multilevel Model, GEE, Survival Analysis, Time Series and etc.
    • Supervising (Linear/Logistic regression and etc.)/Unsupervising Learning (K-mean Clustering, DBSCAN and etc.)
    • Data Modeling: Linear/Logistic regression, Ridge, LASSO, Elastic Net, GLM, PCR, PLS, LDA, QDA and etc.
    • Machine Learning: Deep Learning, Neural Network, Random Forests, XGBoost, SVM and etc.
    • Others: Meta-Analysis, Reliability Analysis, Sensitivity Analysis and etc.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chen CS, Krishnakumar T, Rowles W, Anderson A, Zhao C, Do L, Bove R. Comparison of MS inflammatory activity in women using continuous versus cyclic combined oral contraceptives. Mult Scler Relat Disord. 2020 Feb 06; 41:101970. PMID: 32088652.
      View in: PubMed
    2. Block VJ, Zhao C, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Henry R, Gelfand JM, Cree BA. Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosis. Mult Scler J Exp Transl Clin. 2019 Oct-Dec; 5(4):2055217319888660. PMID: 31803492.
      View in: PubMed
    3. Krysko KM, Henry RG, Cree BAC, Lin J, Caillier S, Santaniello A, Zhao C, Gomez R, Bevan C, Smith DL, Stern W, Kirkish G, Hauser SL, Oksenberg JR, Graves JS. Telomere Length Is Associated with Disability Progression in Multiple Sclerosis. Ann Neurol. 2019 11; 86(5):671-682. PMID: 31486104.
      View in: PubMed
    4. Cantó E, Barro C, Zhao C, Caillier SJ, Michalak Z, Bove R, Tomic D, Santaniello A, Häring DA, Hollenbach J, Henry RG, Cree BAC, Kappos L, Leppert D, Hauser SL, Benkert P, Oksenberg JR, Kuhle J. Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years. JAMA Neurol. 2019 Aug 12. PMID: 31403661.
      View in: PubMed
    5. Bove R, Rankin K, Lin C, Zhao C, Correale J, Hellwig K, Michel L, Laplaud DA, Chitnis T. Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis. Mult Scler. 2019 Aug 01; 1352458519865118. PMID: 31368394.
      View in: PubMed
    6. Didonna A, Cantó E, Shams H, Isobe N, Zhao C, Caillier SJ, Condello C, Yamate-Morgan H, Tiwari-Woodruff SK, Mofrad MRK, Hauser SL, Oksenberg JR. Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation. J Autoimmun. 2019 Jul; 101:56-69. PMID: 31010726.
      View in: PubMed
    7. Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL. Silent progression in disease activity-free relapsing multiple sclerosis. Ann Neurol. 2019 05; 85(5):653-666. PMID: 30851128.
      View in: PubMed
    8. Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM. Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis. JAMA Netw Open. 2019 03 01; 2(3):e190570. PMID: 30874777.
      View in: PubMed
    9. Bove RM, Rush G, Zhao C, Rowles W, Garcha P, Morrissey J, Schembri A, Alailima T, Langdon D, Possin K, Gazzaley A, Feinstein A, Anguera J. A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study. Neurol Ther. 2019 Jun; 8(1):135-145. PMID: 30506301.
      View in: PubMed
    10. Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM. Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis. Mult Scler. 2019 10; 25(11):1526-1534. PMID: 30141729.
      View in: PubMed
    11. Zhao C, Syed H, Hassan SS, Singh VK, Ahmad Z. Functional importance of aIle-346 and aIle-348 in the catalytic sites of Escherichia coli ATP synthase. Arch Biochem Biophys. 2016 Feb 15; 592:27-37. PMID: 26775572.
      View in: PubMed
    12. Zhao C.. Current research situation of antibacterial peptides. Friend of Science Amateurs Journal. 2008; (C):147 - 149.